Historical record - last NADAC effective date: 12/21/2022
Product Information
CLOBAZAM 10 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3685 per EA under NDC 31722063901. Its NADAC has been published 207 times since Jan 23, 2019.
FDA first approved this application on Oct 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722063901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
12/21/2022
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA209795FDA Approved
10/22/2018
TE Code
AB
On Market Since
10/22/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 10 MG TABLET has been published 207 times since Jan 23, 2019, and over the history we have for it it has declined 62.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3685 per EA |
|---|---|
| All-time high | $0.9696 (Feb 13, 2019) |
| All-time low | $0.2996 (Dec 22, 2021) |
| Median price | $0.4019 |
| Average price | $0.4254 |
| Largest weekly change | +31.2% (Nov 20, 2019) |
| Weeks tracked | 207 |
| Tracking since | Jan 23, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+11.7%
All
-62.0%
Last surveyed Jan 4, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clobazam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBAZAM 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 10 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.3685 per EA (NDC 31722063901), effective Jan 4, 2023.
How has the price of CLOBAZAM 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 10 MG TABLET has declined 62.0%. It has been tracked across 207 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 10 MG TABLET?
Since Jan 23, 2019, the NADAC for CLOBAZAM 10 MG TABLET has ranged from a low of $0.2996 (Dec 22, 2021) to a high of $0.9696 (Feb 13, 2019), with a median of $0.4019 per EA.
Are there cheaper alternatives to CLOBAZAM 10 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBAZAM 10 MG TABLET, is $0.2427 per EA — about 34% below CLOBAZAM 10 MG TABLET.
Who manufactures CLOBAZAM 10 MG TABLET?
CLOBAZAM 10 MG TABLET (NDC 31722063901) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.